Introduction
Sebaceous adenoma (SA) is an uncommon benign adnexal tumor derived from sebaceous glands, most frequently located on the face, scalp, and trunk. The eyelid represents one of the rarest periocular sites due to the abundance of Meibomian and Zeiss glands. Among the periocular tissues eyelid is one of the most frequent locations. Other such common locations are face or scalp [1]. SA is typically asymptomatic but can present as a slow-growing, painless mass, often resembling tumor of epidermal or stromal origin and sometimes metastatic [2]. Physical examination reveals yellowish, smooth, well-circumscribed soft or firm nodules on the eyelid margin measuring a size of few millimetres to several centimetres in diameter [3]. SA is composed of both sebaceous (which contain lipid-rich cytoplasm) and basaloid cells (with dark-staining nuclei) which may have areas of cystic change, focal necrosis and calcification. Standard method of diagnosis is clinical examination and histopathology for confirmation. Immunohistochemical staining is typically positive for Adipophilin, AR, CK7 [4]. The distinction between sebaceous adenomas, sebaceoma and other tumors like sebaceous carcinoma is important for final diagnosis [5]. Although histopathologic features of SA are well recognized, variations in clinical morphology and age of presentation make each case diagnostically significant. This case emphasizes a pseudopapillomatous sebaceous adenoma of the eyelid in an elderly male, a presentation rarely documented in literature, and discusses its differentiation from sebaceous carcinoma and syndromic associations.
CASE REPORT
An 81-year-old man presented to the ophthalmology outpatient department with complaints of blurring of vision in the left eye. Best corrected visual acuity was 20/40 in the right eye and 20/120 in the left. On examination, a 1 × 1 cm exophytic, yellowish-pink papillomatous lesion was noted on the left lower eyelid. The lesion had been slowly increasing in size for several years without pain or discharge. There was no prior history of similar lesions on the face or elsewhere and no personal or family history of visceral malignancy. The lesion was excised and submitted for histopathological and immunohistochemical analysis. Gross Findings showed a grey-white tissue fragment measuring 0.5 × 0.2 × 0.2 cm. Microscopic Findings showed the tumor was lined by stratified squamous epithelium. Subepithelial tissue showed well-circumscribed lobules of sebocytes with vacuolated cytoplasm and a peripheral layer of basaloid cells. No nuclear atypia, necrosis, or mitotic activity was noted (Figures 1–4). Immunohistochemistry for Epithelial Membrane Antigen (EMA) showed Diffuse cytoplasmic positivity confirming sebaceous differentiation and Ki-67 showed low proliferative index (<5%), supporting benign behaviour (Figure 5–8).

Figure 1. Clinical image showing yellowish papillomatous exophytic lesion in the left lower eyelid

Figure 2. Low-power photomicrograph shows a well-circumscribed, lobulated dermal tumor composed of variably sized sebaceous lobules The lobules demonstrate peripheral basaloid germinative cells with central areas of mature sebocytes showing abundant foamy/vacuolated cytoplasm. No significant cytologic atypia or infiltrative growth is identified (H&E, 10X).
![Section shows lobules of sebaceous gland proliferation with benign features [H&E, 10x]](https://oncoscience-beta-ssr.nyc3.cdn.digitaloceanspaces.com/article/655/figure/F3/large.png)
Figure 3. Section shows lobules of sebaceous gland proliferation with benign features [H&E, 10x]

Figure 4. High-power photomicrograph shows sebaceous lobules composed of peripheral layers of small basaloid germinative cells transitioning toward centrally located mature sebocytes with abundant clear, multivacuolated (lipid-rich) cytoplasm and small, centrally placed nuclei No significant nuclear atypia, necrosis, or increased mitotic activity is identified (H&E, 40X).

Figure 5. Immunohistochemistry for epithelial membrane antigen (EMA) demonstrates cytoplasmic positivity in mature sebocytes within the tumor lobules, highlighting sebaceous differentiation (IHC, 4X).

Figure 6. High power view of immunohistochemistry EMA positivity supports diagnosis of sebaceous adenoma (IHC, 10X).

Figure 7. Low power view of Ki-67 immunohistochemistry shows mature sebocytes are largely negative The low Ki-67 labeling index supports the benign nature of Sebaceous Adenoma. (IHC, 10X).

Figure 8. High power view of Ki-67 immunohistochemistry shows low proliferative activity (IHC, 40X)
Based on morphology and IHC profile, the lesion was diagnosed as sebaceous adenoma. Screening for mismatch repair (MMR) gene deficiency (MLH1, MSH2, MSH6, PMS2) was discussed but deferred as the patient had no relevant family history or other lesions.
Discussion
Sebaceous adenoma is a benign neoplasm composed of lobules of sebaceous cells showing varying degrees of differentiation. Though histological features are well described, pseudopapillomatous morphology of eyelid SA in an elderly individual is rare and clinically mimics papilloma or carcinoma. This morphological variant and the associated diagnostic dilemma constitute the novelty of our report. The incidence of SA is less than 1% among sebaceous tumors, with the eyelid being an uncommon location [1, 5]. The lesion often presents diagnostic difficulty due to clinical similarity with papillomatous or malignant adnexal lesions.
Our case exhibited a papillomatous external appearance but lacked a fibrovascular core microscopically, instead showing expanded lobules of sebaceous cells beneath stratified squamous epithelium. The basaloid peripheral rim and central mature sebocytes were diagnostic of SA. The absence of mitoses or nuclear atypia differentiated it from sebaceous carcinoma. On clinical examination morphological diagnosis can be made using slit lamp biomicroscopy. Most common morphological features of pathologies are papillomatous, diffuse, nodular with or without ulceration and induration.[6, 7] The association of sebaceous neoplasms with Muir-Torre syndrome has been extensively reviewed in literature, emphasizing the importance of systemic evaluation in affected patients [8, 9]. Shields et al. reported on a large series of sebaceous carcinoma cases, highlighting the clinical challenge in distinguishing benign from malignant sebaceous lesions [10]. Histopathologic evaluation is critical as sebaceous tumors can display a broad spectrum of differentiation, often requiring expertise for accurate classification [11]. A comprehensive understanding of eyelid tumor pathology is essential due to their wide histological variety and potential systemic associations [12]. Sebaceous adenomas may closely mimic sebaceous carcinoma; thus, awareness of these mimics is vital for pathologists [13]. Emerging insights into the pathogenesis of sebaceous tumors suggest roles for molecular alterations in tumor classification and diagnosis [14]. Epidemiological data indicate a rising incidence of sebaceous neoplasms, possibly due to increased recognition and improved diagnostic techniques [15]. In the present case, papilloma was the clinical diagnosis and on histopathology sebaceous gland abnormal proliferation was found. Histopathologically, sebaceous gland proliferation is characterised by vacuolated sebocytes. These are the common abnormalities in the head and neck region which has less propensity for malignant transformation [5]. Pathologies arising from sebaceous gland include hyperplasia, adenoma, carcinoma, sebaceoma. Sebaceous hyperplasia is characterised by papulomatous mature sebaceous gland which are larger than normal. Sebaceous adenoma is a well circumscribed lesion which is located primarily in dermis and sometimes associated with Muir-torre syndrome (MTS). The central sebocytes are more mature than peripheral. The peripheral basal cell layer is thick in SA [6]. SA is differentiated from sebaceomas on the basis of the thickness of the basal cells. If it is more than 50% of the tumor volume then tumors are sebaceomas. Sebaceomas are also well circumscribed lesions located in the dermis with almost no connection with the overlying epidermis. Basal cells are located in the periphery while sebaceous cells in the centre of the lesion and are often associated with MTS but not always like the present case does not have any history of the genetic disease [3, 6]. Often lesions of sebaceous glands are over diagnosed as carcinomatous clinically, hence histopathology becomes an important tool for differentiation [5]. Sebaceous carcinoma on microscopy is an irregular lobular growth composed of atypical sebaceous polygonal cells with a fibrovascular stroma. Central portion of tumor may be necrotic. The well differentiated neoplasm cells have abundant cytoplasm with oval vesicular nuclei with distinct nucleoli while poorly differentiated have high nucleus to cytoplasmic ratio having basaloid growth or infiltrative growth [3].
The spectrum of sebaceous neoplasm is discussed in Comparative Table 1 [6]. Sebaceous hyperplasia, sebaceoma, and sebaceous carcinoma remain key differentials. Sebaceous hyperplasia shows enlarged sebaceous lobules centered on a duct with mature sebocytes and minimal basaloid proliferation. Sebaceoma shows >50% basaloid cells, and sebaceous carcinoma demonstrates cytologic atypia and invasion. IHC analysis further aided in confirming diagnosis. EMA positivity established sebaceous differentiation, while a low Ki67 index (<5%) confirmed low proliferative potential. These findings were consistent with benign behavior and helped to rule out sebaceous carcinoma, which typically exhibits a high Ki-67 index and loss of EMA in undifferentiated regions [16]. Although Muir–Torre syndrome (MTS) is a known association with sebaceous neoplasms, the patient had no family or personal history of visceral malignancies. Routine MMR testing may not be required in elderly isolated cases; however, it is advisable in younger patients, multiple lesions, or unusual histology [7, 9].
Table 1. Spectrum of sebaceous neoplasms
| Histological features | Sebaceous hyperplasia | Sebaceous adenoma | Sebaceoma | Sebaceous carcinoma |
|---|---|---|---|---|
| Architecture | Enlarged lobules with central duct | Well-circumscribed lobules | Well-circumscribed, basaloid >50% | Irregular, infiltrative |
| Sebaceous differentiation | >70% | 50–70% | <50% | Variable, often <50% |
| Basaloid component | Minimal | <50% | >50% | Predominant, pleomorphic |
| Atypia | Absent | None | Minimal | Marked |
| Mitoses | Rare | Few | Few–numerous | Numerous, atypical |
| Necrosis | Absent | Absent | Absent | Common |
| Invasion | Absent | Absent | Absent | Present (dermal or deep invasion) |
| Association with No MTS | Possible | Possible | Frequent |
Conclusions
Sebaceous adenoma of the eyelid is a rare, benign sebaceous neoplasm that can mimic papillomatous or malignant lesions. Its pseudo-papillomatous appearance, low Ki-67 index, and EMA positivity confirm its benign nature. Thorough histopathological and immunohistochemical evaluation is crucial to rule out sebaceous carcinoma and Muir–Torre syndrome. This case adds to literature by describing an unusual papillomatous variant of eyelid sebaceous adenoma in an elderly patient with supportive IHC findings.
Author Contributions
Dr Gunvanti Rathod-corrected the first draft and critically reviewed the manuscript. Dr Monica Mishra and Dr Sai Swetha -done a literature search, and prepared the first draft of the manuscript. Dr Siddharam Janti-provided the provisional diagnosis and planned the procedure. Dr Shamli Zalke- Did the excision biopsy under the guidance of Dr Raghavendra. Dr Raghavendra Rao- Provided clinical and reviewed the article.
Conflicts of Interest
Authors have no conflicts of interest to declare.
Editorial Note
ETHICAL STATEMENT
The authors affirm that all ethical principles were followed as per the Declaration of Helsinki (2013 revision). Institutional ethical approval was not required for single-patient case reports as per the Institutional policy.
Editorial Note
CONSENT
Written informed consent was obtained from the patient for publication of this case report and accompanying images.
Funding
No funding was used for this paper.
References
- 1. Singh AD, Mudhar HS, Bhola R, Rundle PA, Rennie IG. Sebaceous adenoma of the eyelid in Muir-Torre syndrome. Arch Ophthalmol. 2005; 123:562–65. https://doi.org/10.1001/archopht.123.4.562. [PubMed]
- 2. Takayama K, Usui Y, Ito M, Goto H, Takeuchi M. A case of sebaceous adenoma of the eyelid showing excessively rapid growth. Clin Ophthalmol. 2013; 7:667–70. https://doi.org/10.2147/OPTH.S42135. [PubMed] .
- 3. Arzbecker M, Bryar PJ, Thyparampil PJ. Sebaceous carcinoma presenting as chronic chalazion. BMJ Case Rep. 2025; 18:e258895. https://doi.org/10.1136/bcr-2023-258895. [PubMed]
- 4. Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989; 33:477–90. https://doi.org/10.1016/0039-6257(89)90049-0. [PubMed]
- 5. Atanu B, Bipasha M, Sonam PN, Subramanian K. Reverse masquerade: Benign sebaceous tumors mimicking sebaceous gland carcinoma of the eyelid. Indian J Ophthalmol. 2021; 1:80–82. https://doi.org/10.4103/ijo.IJO_758_20
- 6. Pereira
PR, Odashiro
AN, Rodrigues-Reyes
AA, Correa
ZM, de Souza Filho
JP, Burnier
MN
Jr . Histopathological review of sebaceous carcinoma of the eyelid. J Cutan Pathol. 2005; 32:496–501. https://doi.org/10.1111/j.0303-6987.2005.00371.x. [PubMed] - 7. Muqit MM, Foot B, Walters SJ, Mudhar HS, Roberts F, Rennie IG. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophthalmol. 2013; 97:47–51. https://doi.org/10.1136/bjophthalmol-2012-302443. [PubMed]
- 8. Nemoto Y, Arita R, Mizota A, Sasajima Y. Differentiation between chalazion and sebaceous carcinoma by noninvasive meibography. Clin Ophthalmol. 2014; 8:1869–75. https://doi.org/10.2147/opth.s69804. [PubMed] .
- 9. Sahu SK, Sen S, Poddar C. Sebaceous Gland Carcinoma of Lid: Masquerading as a Recurring Chalazion. Int J Appl Basic Med Res. 2021; 11:117–19. https://doi.org/10.4103/ijabmr.IJABMR_652_20. [PubMed] .
- 10. Fuente García C, Pinilla-Pagnon I, Albandea Jiménez A, Sales-Sanz M. Sebaceous carcinoma mimicking a chalazion in a young patient. Arch Soc Esp Oftalmol (Engl Ed). 2018; 93:e56–57. https://doi.org/10.1016/j.oftal.2017.11.001. [PubMed]
- 11. Gerber DM, Meyer P, Messerli JO, Piffaretti JM, Haefliger IO. Maskerade eines Talgdrüsenkarzinoms durch ein rasch rezidivierendes “Chalazion”, eine Kasuistik [Masquerade of sebaceous gland carcinoma as a rapidly recurring “chalazion”, a case report]. Klin Monbl Augenheilkd. 2001; 218:391–93. https://doi.org/10.1055/s-2001-15909. [PubMed]
- 12. Pandey S, Sharma V, Titiyal GS, Satyawali V. Sequential occurrence of basal cell carcinoma in symmetrically identical positions of both lower eyelids: A rare finding of a common skin cancer. Oman J Ophthalmol. 2010; 3:145–47. https://doi.org/10.4103/0974-620X.71895. [PubMed] .
- 13. Giner EA, Santiago A, Gómez-Gallego M, Ramírez de Arellano C, Poulten RC, Whittlesey MK, Sierra MA. Mono- and bimetallic zwitterionic chromium(0) and tungsten(0) allenyls. Inorg Chem. 2015; 54:5450–61. https://doi.org/10.1021/acs.inorgchem.5b00492. [PubMed]
- 14. Li F, Zou Z, Yong HY, Kitashiba H, Nishio T. Nucleotide sequence variation of GLABRA1 contributing to phenotypic variation of leaf hairiness in Brassicaceae vegetables. Theor Appl Genet. 2013; 126:1227–36. https://doi.org/10.1007/s00122-013-2049-1. [PubMed]
- 15. Loke VL, Mengüç MP. Surface waves and atomic force microscope probe-particle near-field coupling: discrete dipole approximation with surface interaction. J Opt Soc Am A Opt Image Sci Vis. 2010; 27:2293–303. https://doi.org/10.1364/JOSAA.27.002293. [PubMed]
- 16. Helmi HA, Alsarhani W, Alkatan HM, Al-Rikabi AC, Al-Faky YH. Sebaceous Gland Carcinoma with Misleading Clinical Appearance: A Case Report of an Eyelid Lesion. Am J Case Rep. 2020; 21:e925134. https://doi.org/10.12659/AJCR.925134. [PubMed] .


